“…A recent investigation identified PDK4 [374], ALB (albumin) [375], CYP27B1 [376], PCK1 [377], TET2 [378], EGF (epidermal growth factor) [379], LPL (lipoprotein lipase) [380], PLG (plasminogen) [381], NR4A2 [382], SLC1A1 [383], OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) [384], ERBB4 [385], L3MBTL3 [386], NAPEPLD (N-acyl phosphatidylethanolamine phospholipase D) [387], HTRA1 [388], CBLB (Cbl proto-oncogene B) [389], PDGFRA (platelet derived growth factor receptor alpha) [390], KL (klotho) [391], LRP2 [392], BTLA (B and T lymphocyte associated) [393], RGS1 [394], S100A12 [395], ND2 [396], CCL22 [397], ICOS (inducible T cell costimulator) [398], CNR2 [399], DBH (dopamine beta-hydroxylase) [400], CD5 [401], LTA (lymphotoxin alpha) [402], IFNG (interferon gamma) [403], MPO (myeloperoxidase) [404], CD70 [405], IRF4 [406], VAV1 [407], IKZF3 [408], BTK (Bruton tyrosine kinase) [409], LCN2 [410], TREM2 [411], CD27 [412], F12 [413], CCR5 [414], CX3CR1 [415], IL21R [416], CYBB (cytochrome b-245 beta chain) [417], IL11 [418], TRPM2 [419], EOMES (eomesodermin) [420], TNF (tumor necrosis factor) [421], CD2 [422], SEMA7A [423], TLR7 [424], CCL3 [425], NOD2 [426], CCR2 [427], CCL5 [428], TH (tyrosine hydroxylase) [429], SIGLEC1 [430], HBD (hemoglobin subunit delta) [431], NOS3 [432], SIGLEC7 [433], IL2RB [434], RETN (resistin) [435] and S100B [436] as major genes contributing to multiple sclerosis. Musante et al [437], Han et al [438], Zhang et al [439], Sato et al [440], Yang et al [441...…”